Jay Gellert - Ventas Independent Director
| VTR Stock | USD 66.53 1.59 2.45% |
Director
Mr. Jay M. Gellert is an Independent Director of Ventas, Inc. He was President and Chief Executive Officer of Health Net, Inc., an integrated managed care organization that administers the delivery of managed healthcare services, since 1998 and a director of Health Net since 1999. He served as President and Chief Operating Officer of Health Net from 1997 to 1998 and as President, Chief Operating Officer and a director of its predecessor, Health Systems International, Inc., a health maintenance organization, from 1996 to 1997. Before joining HSI, Mr. Gellert directed strategic advisory engagements for Shattuck Hammond Partners in the area of integrated delivery systems development, managed care network formation and physician group practice integration. He has also previously served as President and Chief Executive Officer of Bay Pacific Health Corporationrationration, Senior Vice President and Chief Operating Officer for California Healthcare System and as an independent consultant. Mr. Gellert is currently a member of the Board of Directors of Americas Health Insurance Plans. since 2001.
| Age | 66 |
| Tenure | 24 years |
| Address | 353 North Clark Street, Chicago, IL, United States, 60654-4708 |
| Phone | 877 483 6827 |
| Web | https://www.ventasreit.com |
Ventas Management Efficiency
The company has Return on Asset of 0.018 % which means that on every $100 spent on assets, it made $0.018 of profit. This is way below average. Ventas' management efficiency ratios could be used to measure how well Ventas manages its routine affairs as well as how well it operates its assets and liabilities. As of 02/18/2025, Return On Tangible Assets is likely to drop to 0. In addition to that, Return On Capital Employed is likely to drop to 0.03. At this time, Ventas' Asset Turnover is relatively stable compared to the past year.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Kapila Anand | Omega Healthcare Investors | 67 | |
| Dana Hambly | National Health Investors | N/A | |
| Peter Lyle | Healthcare Realty Trust | 56 | |
| Robert Webb | National Health Investors | 76 | |
| Kimberly Ouimet | National Health Investors | N/A | |
| Huiqi Zhang | Global Medical REIT | 31 | |
| Edward Braman | Healthcare Realty Trust | 64 | |
| Nancy Agee | Healthcare Realty Trust | 68 | |
| Ronald Marston | Global Medical REIT | 78 | |
| Henry Cole | Global Medical REIT | 76 | |
| James Jobe | National Health Investors | 59 | |
| Edward Lowenthal | Omega Healthcare Investors | 75 | |
| Kevin Jacobs | Omega Healthcare Investors | 47 | |
| Robert Adams | National Health Investors | 74 | |
| Paula Crowley | Global Medical REIT | 66 | |
| Stephen Plavin | Omega Healthcare Investors | 60 | |
| John Abbott | Healthcare Realty Trust | 66 | |
| Robert McCabe | National Health Investors | 70 | |
| Christann Vasquez | Healthcare Realty Trust | 60 | |
| Matthew Cypher | Global Medical REIT | 44 | |
| Charlotte Swafford | National Health Investors | 73 | |
Management Performance
| Return On Equity | 0.0084 | ||||
| Return On Asset | 0.018 |
Ventas Inc Leadership Team
Elected by the shareholders, the Ventas' board of directors comprises two types of representatives: Ventas inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ventas. The board's role is to monitor Ventas' management team and ensure that shareholders' interests are well served. Ventas' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ventas' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edmund III, Chief VP | ||
| Carey JD, General VP | ||
| Jay Gellert, Independent Director | ||
| Richard JD, Senior Advisor | ||
| Maurice Smith, Independent Director | ||
| Richard Gilchrist, Independent Director | ||
| Louise Adhikari, VP Communications | ||
| Robert Probst, Chief Financial Officer, Executive Vice President | ||
| J Hutchens, Executive Vice President - Senior Housing | ||
| Roxanne Martino, Independent Director | ||
| Justin Hutchens, Executive Officer | ||
| Randy Sohanaki, Vice President - IT Applications | ||
| Julie Robinson, Senior Investments | ||
| Brian Wood, Chief VP | ||
| John Cobb, Executive Vice President, Chief Investment Officer | ||
| Peter Bulgarelli, Executive Vice President and President and Chief Executive Officer, Lillibridge Healthcare Services, Inc. | ||
| Bhavana Devulapally, Senior Vice President, Chief Information Officer | ||
| Michael Embler, Independent Director | ||
| Walter Rakowich, Independent Director | ||
| Debra Cafaro, Chairman of the Board, Chief Executive Officer | ||
| Gregory Liebbe, Senior Vice President Chief Accounting Officer, Controller | ||
| Robert Reed, Independent Director | ||
| Timothy Sanders, Senior Investment Officer | ||
| Christian Cummings, Senior Housing | ||
| Melody Barnes, Independent Director | ||
| James Shelton, Presiding Independent Director | ||
| Matthew Lustig, Independent Director | ||
| Sean Nolan, Independent Director | ||
| Carey Roberts, Executive Vice President General Counsel and Ethics & Compliance Officer | ||
| Marguerite Nader, Independent Director |
Ventas Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ventas a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0084 | ||||
| Return On Asset | 0.018 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 41.93 B | ||||
| Shares Outstanding | 437.14 M | ||||
| Shares Owned By Insiders | 0.56 % | ||||
| Shares Owned By Institutions | 99.51 % | ||||
| Number Of Shares Shorted | 12.13 M | ||||
| Price To Earning | 909.80 X |
Additional Tools for Ventas Stock Analysis
When running Ventas' price analysis, check to measure Ventas' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventas is operating at the current time. Most of Ventas' value examination focuses on studying past and present price action to predict the probability of Ventas' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventas' price. Additionally, you may evaluate how the addition of Ventas to your portfolios can decrease your overall portfolio volatility.